NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/jef-feeley-riley-griffin
Sign In To follow
The trial of Insys Therapeutics Inc. CEO John Kapoor could serve as a test-drive for how jurors weigh claims of industry wrongdoing.